N-n-undecyl-ethylamine | 59570-04-6

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: N-n-undecyl-ethylamine
• 英文别名: N-Ethylundecan-1-amine
• CAS: 59570-04-6
• 化学式: C₁₃H₂₉N
• 分子量: 199.38
• InChiKey: LKVBHKWFYHKTSM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.2
• 重原子数：
  14
• 可旋转键数：
  11
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  12
• 氢给体数：
  1
• 氢受体数：
  1

文献信息

• Novel perfluoropolyether derivatives, and lubricants and magnetic recording medium using the same
  申请人：SONY CORPORATION

  公开号：EP0519406A2

  公开（公告）日：1992-12-23

  Novel perfluoropolyether derivatives are described which are obtained from perfluoropolyethers having a carboxyl group at one or both ends and monoamines or diamines. The derivative is useful as a lubricant owing to its significantly improved lubricity. The lubricity is shown under severe high or low temperature and humidity conditions over a long term. The derivative is especially useful as a lubricant for magnetic recording mediums of the coating and metal thin film types.

  本文描述了新型全氟聚醚衍生物，该衍生物由一端或两端带有羧基的全氟聚醚和单胺或二胺制成。这种衍生物的润滑性能显著提高，可用作润滑剂。这种润滑性可在严酷的高温或低温和潮湿条件下长期保持。该衍生物特别适用于涂层型和金属薄膜型磁记录介质的润滑剂。
• USES OF RECOMBINANT YEAST-DERIVED SERUM ALBUMIN
  申请人：Albumedix Ltd

  公开号：EP3791719A1

  公开（公告）日：2021-03-17

  The invention relates to a methods and uses for the preservation of stem cells, by a method comprising the steps of combining the stem cells with a cryopreservation medium to produce a mixture, and freezing the mixture to produce a frozen stem cell product, optionally, wherein the method further comprises the steps of thawing the frozen stem cell product, transferring the thawed cells to a storage medium, and storing stem cells in the storage medium, wherein the cryopreservation medium and/or the storage medium comprises a recombinant yeast-derived serum albumin preparation, more preferably wherein the recombinant yeast-derived serum albumin preparation is present in the cryopreservation medium and is also present in the storage medium. The invention also relates to methods and uses for the preservation of stem cells, by a method comprising storing stem cells in a storage medium, wherein the stem cells have been frozen in a cryopreservation medium, thawed, and then transferred to the storage medium prior to storage; and wherein the cryopreservation medium and/or the storage medium comprises a recombinant yeast-derived serum albumin preparation, more preferably wherein the recombinant yeast-derived serum albumin preparation is present in the cryopreservation medium and is also present in the storage medium.

  本发明涉及一种保存干细胞的方法和用途，该方法包括以下步骤：将干细胞与低温保存介质结合生成混合物，并冷冻该混合物以生成冷冻干细胞产品，可选地，该方法还包括以下步骤：解冻冷冻干细胞产品、将解冻的细胞转移到储存介质中，并将干细胞储存在储存介质中，其中低温保存介质和/或储存介质包括重组酵母衍生血清白蛋白制剂，更优选地，其中重组酵母衍生血清白蛋白制剂存在于低温保存介质中，也存在于储存介质中。本发明还涉及保存干细胞的方法和用途，其方法包括将干细胞储存在储存介质中，其中干细胞已在低温保存介质中冷冻、解冻，然后在储存前转移到储存介质中；其中低温保存介质和/或储存介质包括重组酵母衍生的血清白蛋白制剂，更优选地，重组酵母衍生的血清白蛋白制剂存在于低温保存介质中，也存在于储存介质中。
• Thermoplastic resin composition
  申请人：NIPPON NYUKAZAI CO., LTD.

  公开号：US10113049B2

  公开（公告）日：2018-10-30

  [Problem] Provided is a thermoplastic resin composition excellent in weather resistance. [Solution] A thermoplastic resin composition containing (a) a thermoplastic resin and (b) an ionically bonded salt represented by the following Chemical Formula (1) or (2): in the Chemical Formulae (1) and (2) above, R1 and R2 each independently represent a substituted or unsubstituted linear, branched, or cyclic alkyl group having from 1 to 30 carbon atoms, a substituted or unsubstituted aryl group having from 6 to 30 carbon atoms, or a substituted or unsubstituted arylalkyl group having from 7 to 31 carbon atoms, A is a linear or branched alkylene group having from 2 to 4 carbon atoms, n represents an integer of 0 to 50, Q1 and Q2 each independently represent at least one kind selected from the group consisting of an ammonium ion, an imidazolium ion, a pyridinium ion, a pyrrolidinium ion, a pyrrolinium ion, a piperidinium ion, a pyrazinium ion, a pyrimidinium ion, a triazolium ion, a triazinium ion, a quinolinium ion, an isoquinolinium ion, an indolinium ion, a quinoxalinium ion, a piperazinium ion, an oxazolinium ion, a thiazolinium ion, and a morpholinium ion.

  [问题]提供一种耐候性优异的热塑性树脂组合物。 [解决方案] 一种热塑性树脂组合物，含有 (a) 热塑性树脂和 (b) 由以下化学式（1）或（2）表示的离子键盐： 在上述化学式（1）和（2）中，R1 和 R2 各自独立地代表具有 1 至 30 个碳原子的取代或 未取代的直链、支链或环状烷基、具有 6 至 30 个碳原子的取代或未取代的芳基或具有 7 至 31 个碳原子的取代或未取代的芳烷基，A 是具有 2 至 4 个碳原子的直链或支链亚烷基，n 代表 0 至 50 的整数、Q1 和 Q2 各自独立地代表至少一种选自以下组成的组的物质：铵离子、咪唑鎓离子、吡啶鎓离子、吡咯烷鎓离子、吡咯烷鎓离子、哌啶鎓离子、吡嗪鎓离子嘧啶鎓离子、三唑鎓离子、三嗪鎓离子、喹啉鎓离子、异喹啉鎓离子、吲哚鎓离子、喹喔啉鎓离子、哌嗪鎓离子、噁唑啉鎓离子、噻唑啉鎓离子和吗啉鎓离子。
• THERMOPLASTIC RESIN COMPOSITION
  申请人：NIPPON NYUKAZAI CO., LTD.

  公开号：US20150329698A1

  公开（公告）日：2015-11-19

  [Problem] Provided is a thermoplastic resin composition excellent in weather resistance. [Solution] A thermoplastic resin composition containing (a) a thermoplastic resin and (b) an ionically bonded salt represented by the following Chemical Formula (1) or (2): in the Chemical Formulae (1) and (2) above, R 1 and R 2 each independently represent a substituted or unsubstituted linear, branched, or cyclic alkyl group having from 1 to 30 carbon atoms, a substituted or unsubstituted aryl group having from 6 to 30 carbon atoms, or a substituted or unsubstituted arylalkyl group having from 7 to 31 carbon atoms, A is a linear or branched alkylene group having from 2 to 4 carbon atoms, n represents an integer of 0 to 50, Q1 and Q2 each independently represent at least one kind selected from the group consisting of an ammonium ion, an imidazolium ion, a pyridinium ion, a pyrrolidinium ion, a pyrrolinium ion, a piperidinium ion, a pyrazinium ion, a pyrimidinium ion, a triazolium ion, a triazinium ion, a quinolinium ion, an isoquinolinium ion, an indolinium ion, a quinoxalinium ion, a piperazinium ion, an oxazolinium ion, a thiazolinium ion, and a morpholinium ion.
• METHOD OF INHIBITION OF LEUKEMIC STEM CELLS
  申请人：CSL Limited

  公开号：US20170029515A1

  公开（公告）日：2017-02-02

  A method for inhibition of leukemic stem cells expressing IL-3Rα (CD123), comprises contacting the cells with an antigen binding molecule comprising a Fc region or a modified Fc region having enhanced Fc effector function, wherein the antigen binding molecule binds selectively to IL-3Rα (CD123). The invention includes the treatment of a hematologic cancer condition in a patient by administration to the patient of an effective amount of the antigen binding molecule.